Enhancing Neuro-Oncology treatment planning

In the US, over 20,000  adults and over 3,000 children were diagnosed with brain cancers in 2017. From the first diagnosis their lives will never be the same.

23,880

US adults were diagnosed with cancers of brain or spinal column in 2017

3,560

US children were diagnosed with cancers of brain or spinal column in 2017

35%

average 5-year survival rate for people with cancerous brain or CNS tumors

Enhancing Neuro-Oncology treatment planning

In the US, over 20,000  adults and over 3,000 children were diagnosed with brain cancers in 2017. From the first diagnosis their lives will never be the same.

23,880

US adults were diagnosed with cancers of brain or spinal column in 2017

3,560

US children were diagnosed with cancers of brain or spinal column in 2017

35%

average 5-year survival rate for people with cancerous brain or CNS tumors

Diagnosis changes lives

Patients and clinicians are faced with hard choices as to how best to treat brain tumours, as well as how to address the inevitable side effects of the disease and of the various treatment options. Conventional radiation therapies affect areas of the brain unaffected by cancer as well as the diseased tissue; a large proportion of brain cancer survivors suffer cognitive loss due to the treatments that saved their lives. 40% of patients with brain tumours – and 90% of those with tumours due to gliomas – will also experience epileptic seizures.

 

How MEG can benefit oncology treatment planning

MEG localizes brain structures linked to important functions and thereby helps to preserve these functions when receiving oncology treatments like radiation therapy or surgery. This helps oncologists to create optimal treatment plans that identify and mitigate functional and cognitive decline. Using MEG in oncology treatment planning can lead to improved treatment outcomes and better quality of life for brain cancer survivors.

The treatment pipeline with MEG

Before treatment begins

Combined with MRI, MEG can support the oncologist in assessing the impact of a therapy on motor ability, sensory responses, and language processing. In brain tumor patients who also have seizures, MEG provides accurate and precise information on location of the epileptic areas. 

Enhancing effectiveness of

treatment options

MEG is used for pre-surgical functional brain mapping to identify the location of the eloquent cortex. MEG can therefore be used to support treatment planning with targeted options, such as proton beam therapy, to minimize neurological deficit. 

During and post treatment assessments

MEG supports clinical decision making in optimizing treatment planning strategies. It can provide an oncologist valuable insight during ongoing treatment planning. Understanding the brain function can positively impact cancer treatment strategies and patient recovery.

Contact Us

MEGIN Oy
Siltasaarenkatu 18-20
00530 Helsinki
Finland

+358 9 756 2400

info@megin.fi